期刊文献+

FOXP3在人肺腺癌细胞中的表达意义 被引量:3

Clinical Value of FOXP3 Expression in Human Lung Adenocarcinoma Cells
下载PDF
导出
摘要 目的通过检测FOXP3在人肺腺癌细胞中的表达情况,探讨FOXP3在人肺腺癌发生、发展中的作用机制.方法收集临床肺腺癌患者术后石蜡包埋标本42例和正常肺组织10例,采用免疫组化SP法检测FOXP3蛋白的表达水平,分析其在肺癌细胞组与正常支气管黏膜组表达的差异,以及其在肺癌细胞的表达与临床病理指标的内在联系.结果 FOXP3在人肺腺癌细胞高表达,阳性率为64.3%;在正常肺组织低表达,阳性率为20.0%,两组比较差异具有统计学意义(P=0.011).FOXP3蛋白表达与有无淋巴结转移显著相关,有淋巴结转移组FOXP3的阳性表达率为83.3%,无淋巴结转移组FOXP3的阳性表达率为50.0%,两组比较差异具有统计学意义(P=0.026).FOXP3蛋白表达与患者性别、年龄、肿瘤的大小和分化程度均无明显相关性(P>0.05).结论FOXP3参与人肺腺癌的发生、发展,可作为评判肺腺癌恶性生物学行为的指标之一. Objective To explore the role and clinical value of FOXP3 in lung adenocarcinoma,by detecting the expression of FOXP3 protein in the tumor cells of primary lung adenocarcinoma. Method A total of 42 cases specimens from the operated patients with primary lung adenocarcinoma were selected in this study with 15 cases of normal lung tissue as control. FOXP3 expression was detected by immunohistochemistry technique( SP method) and the relationship between FOXP3 expression and clinicopathological features were analyzed.Results The positive expression rate of FOXP3 was 64. 3% in lung adenocarcinoma,which was significantly higher than that of the control group with 20. 0%( P = 0. 011). FOXP3 expression in lung adenocarcinoma was closely associated with lymph node metastasis. The positive rate of FOXP3 in the lymph node metastasis group( 83. 3%) was significantly higher than that of the non-lymph node metastasis group( 50. 0%)( P = 0. 026).While no correlation was found between the expression of FOXP3 and the patients' gender,age,tumor size and differentiation( P 0. 05). Conclusion FOXP3 may play an important role in the tumorigenesis and development of lung adenocarcinoma. Therefore,FOXP3 could be used as one of the markers to evaluate themalignant biological behavior of lung adenocarcinoma.
出处 《北华大学学报(自然科学版)》 CAS 2016年第1期54-57,共4页 Journal of Beihua University(Natural Science)
基金 吉林省科技厅自然科学基金项目(20150101128JC)
关键词 FOXP3 肺腺癌 免疫组化 FOXP3 lung adenocarcinoma immunohistochemistry
  • 相关文献

参考文献14

  • 1Jemal A,Siegel R,Ward E,et al. Cancer statistics,20OS[J]. CA Cancer J Clin,2008,58:71-96.
  • 2Li B, Samanta A, Song X, et al. FOXP3 ensembles in T- cell regulation [ J ]. Immunol Rev,2006,212 : 99-113.
  • 3Ziegler S F. FOXP3 of mice and men [ J ]. Annu Rev Immuno1,2006,24( 1 ) :209-226.
  • 4Schneider T, Kimpfler S, Warth A, et al. Foxp3 regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adeno- carcinoma [ J ]. J Thorac Oncol, 2011,6 ( 3 ) :432-438.
  • 5Shimizu K, Nakata M, Hirami Y, et al. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cycloox- ygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer [ J ]. J Thorac Oncol,2010,5 ( 5 ) :585-590.
  • 6历春,李欣,贾婷,孙际童,付海英.S180腹水癌小鼠肿瘤浸润淋巴细胞中CD4^+CD25^+Treg细胞在肿瘤逃逸中的作用[J].吉林大学学报(医学版),2010,36(6):1094-1097. 被引量:4
  • 7盖晓东,赵丽微,历春.CD4^+CD25^+FOXP3^+调节性T细胞及其亚型在结直肠癌组织中分布和临床意义的研究[J].中国免疫学杂志,2010,26(1):75-78. 被引量:8
  • 8Jaberipour M, Habibagahi M, Hosseini A, et al. Increased CTLA-4 and FOXP3 transcripts in peripheral blood mon-onuclear cells of patients with breast cancer [ J ]. Pathol Oncol Res ,2010,16 (4) :547-551.
  • 9WANG Li-hong SU Lin WANG Jing-tong.Correlation between elevated FOXP3 expression and increased lymph node metastasis of gastric cancer[J].Chinese Medical Journal,2010(24):3545-3549. 被引量:13
  • 10Kim M,Grimmig T,Grimm M,et al. Expression of Foxp3 in colorectal cancer but not in treg cells correlates with disease progression in patients with colorectal cancer [ J ]. PI_oS One ,2013,8( 1 ) : e53630.

二级参考文献42

  • 1Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3[J]. Science,2003;299: 1057-1061.
  • 2Fontenot J D, Gavin M A, Rudensky A Y. FOXP3 programs the development and function of CD4 ^+ CD25 ^+ regulatory T cells[J ]. Nat Immunol, 2003 ; 4 : 330-336.
  • 3Khattri R, Cox T, Yasayko S A et al. An essential role for Scurfin in CD4^+ CD25 ^+ T regulatory cells[ J ]. Nat Immunol, 2003 ;4 : 337-342.
  • 4Ito T,Hanabuchi S, Wang Y H et al. Two functional subsets of FOXP3^+ regulatory T cells in human thymus and periphery[J]. Immunity, 2008; 28 : 870-880.
  • 5萧树乐,许国铭主编.中华胃肠病学[M].北京:人民卫生出版社,2008,493-494.
  • 6Woo E Y, Chu C S, Goletz T Jet al. Regulatory CD4^+ CD25^+ T ceils in tumors from patients with early-stage non-small cell lung cancer and latestage ovarian cancer[J]. Cancer Res,2001 ;61:4766-4772.
  • 7Liyanage U K,Moore T T,Joo H G et al.Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma[J].J Immunol,2002,169:2756-2761.
  • 8Curiel T J, Coukos G, Zou L a al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immtme privilege and predicts reduced survwal[J]. Nat Med,2004; 10:942-949.
  • 9Viguier M, Lernaitre F, Verola O et al. FOXP3 expressing CD4^+ CD25high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells[J]. J Immunol, 2004 ; 173 : 1444-1453.
  • 10Wang H Y, Lee D A, Peng G a al. Tumor-specific human CD4 ^+ regulatory T cells and their ligands: implications for immunotherapy[ J]. Immunity, 2004; 20 : 107-118.

共引文献24

同被引文献53

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部